D
BridgeBio Oncology Therapeutics, Inc. BBOT
$9.71 $0.879.84% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 06/30/2024
Revenue -- -- --
Total Other Revenue -- -- --
Total Revenue -- -- --
Cost of Revenue -- -- --
Gross Profit -- -- --
SG&A Expenses 2.66M 2.50M 1.36M
Depreciation & Amortization -- -- --
Other Operating Expenses -- -- --
Total Operating Expenses 30.09M 23.14M 23.87M
Operating Income -30.09M -23.14M -23.87M
Income Before Tax -28.44M -22.06M -21.82M
Income Tax Expenses -- -- --
Earnings from Continuing Operations -28.44M -22.06M -21.82M
Earnings from Discontinued Operations -- -- --
Extraordinary Item & Accounting Change -- -- --
Minority Interest in Earnings -- -- --
Net Income -28.44M -22.06M -21.82M
EBIT -30.09M -23.14M -23.87M
EBITDA -30.02M -23.08M -23.82M
EPS Basic -50.36 -54.23 -174.97
Normalized Basic EPS -31.48 -33.89 -109.35
EPS Diluted -50.36 -54.23 -174.97
Normalized Diluted EPS -31.48 -33.89 -109.35
Average Basic Shares Outstanding 564.60K 406.70K 124.70K
Average Diluted Shares Outstanding 564.60K 406.70K 124.70K
Dividend Per Share -- -- --
Payout Ratio -- -- --